We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A letter from Jason Dorsett, Finance, Reporting and Risk Director at Monitor.
Following a workshop with other international regulators, MHRA has published information on how we continue to support the development of drugs for dementia today.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
The Medicines and Healthcare products Regulatory Agency (MHRA) will start issuing Certificates of Free Sale (CFS) from Wednesday 1 April 2015.
Lynne Featherstone writes to the chair of the Advisory Council on the Misuse of Drugs (ACMD) about the proposal to consolidate the Misuse of Drugs (Designation) Order 2001.
In this seminar speakers described the joint initiative between the National Offender Management Service and NHS England and how the programme is providing a jointly commissioned pathway of services from community to communi…
Dr Ruth May, a former NHS theatre sister and Chief Nurse, is joining the health sector regulator Monitor.
Charges for NHS prescriptions, dental charges, elastic stockings and tights, wigs and fabric supports and optical voucher values.
Dr Ian Hudson, Chief Executive of Medicines and Healthcare Products Regulatory Agency, comments on the first scientific opinion granted in the UK.
The chair of the Advisory Council on the Misuse of Drugs (ACMD) writes to Lynne Featherstone about the Misuse of Drugs (Designation) Order 2001.
Lynne Featherstone writes to the chair of Advisory Council on the Misuse of Drugs (ACMD) about the rescheduling of ketamine.
Lynne Featherstone writes to the chair of Advisory Council on the Misuse of Drugs (ACMD) on health practitioners independent prescribing.
As part of the 100,000 Genomes Project pilot, the Centre for Life in Newcastle has made its first diagnoses.
The use of genome sequencing to diagnose 2 families with rare diseases has been announced along with other milestones in medical innovation.
Details of a review into plans to give NHS patients quicker access to innovative medicines and medical technology have been announced.
The NHS has chosen 29 ‘vanguard’ geographies to take the national lead on transforming care for patients in towns, cities and counties across England.
A pay deal which will reward more than a million NHS staff with a 1% pay rise has been agreed for 2015 to 2016.
The trust will collaborate with Guy’s and St Thomas’, one of the country’s leading NHS foundation trusts under plans announced today.
A large majority of NHS hospitals, community health services and mental health trusts have decided to move to a new voluntary tariff option for 2015/16.
Online learning module on reducing the side effects of steroid medicines to help clinicians to optimise the use of corticosteroids.
The Secretary of State for Health talks about the investigation into care provided by the maternity and neonatal unit at Morecambe Bay.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).